Cell and gene therapy developers have focused clinical programs around specific regulators in the absence of uniform global standards, with few sponsors successfully attempting approvals in both the US and the EU, a Pink Sheet analysis found.
The US FDA approved 10 cell and gene therapies between January 2023 and April 2024. Seven are not available in...








